GreatBay Bio Launches English Version of AlfaDAX Online Platform for Biologic Drug Molecule Evaluation and Optimization
GBB
AI Biomedical R&D Company
Today, the English version of GBB's biopharmaceutical molecule evaluation and optimization platform, AlfaDAX, was officially launched online.
From now on, the Chinese and English versions of the AlfaDAX online system are fully equipped. Users worldwide can detect the druggability of their biological drug molecules without leaving home, reduce trial-and-error costs, and accelerate the new drug development process. Friends in the life sciences field are welcome to experience.(Searchhttps://store.greatbay-bio.com/, you can scan the QR code below or click on the 'Read More' at the end of the article to experience it for free.)
▲AlfaDAX Online System URL
▲Scan the QR code to experience the AlfaDAX online system in both Chinese and English versions
▲AlfaDAX Online System English Version Operation Tutorial
The AlfaDAX platform integrates protein structure prediction, visualization, analysis, and sequence optimization. Customers can comprehensively evaluate the potential of candidate protein molecules to become developable, safe, and effective drugs through protein structure prediction, hydrophilic/hydrophobic group analysis, positive/negative charge clustering, immunogenicity (humanization), molecular docking, and affinity analysis. Before the candidate protein molecules enter the CMC stage, the AlfaDAX platform helps customers quickly screen and modify candidate molecules, reducing trial-and-error costs and accelerating the new drug development process.
END
Tel: 400 079 8808
18926497707 (Same number on WeChat)
Email: BD@greatbay-bio.com
